Clinical trials
Herpes Zoster trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
93 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 3 |
| 2003 | 1 |
| 2005 | 1 |
| 2006 | 5 |
| 2007 | 4 |
| 2008 | 4 |
| 2009 | 4 |
| 2010 | 8 |
| 2011 | 4 |
| 2012 | 2 |
| 2013 | 4 |
| 2014 | 6 |
| 2015 | 3 |
| 2016 | 3 |
| 2017 | 3 |
| 2018 | 4 |
| 2019 | 3 |
| 2020 | 3 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 7 |
| 2024 | 3 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 73 |
| Terminated | 6 |
| Active, not recruiting | 4 |
| Recruiting | 4 |
| Unknown status | 4 |
| Withdrawn | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 21 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 5 |
| NeurogesX | 5 |
| University of Colorado, Denver | 4 |
| Pfizer | 3 |
| Center for Clinical Studies, Texas | 2 |
| Curevo Inc | 2 |
| Depomed | 2 |
| Emory University | 2 |
| Immorna Biotherapeutics, Inc. | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Herpes Zoster | 93 |
| Neuralgia, Postherpetic | 21 |
| Chickenpox | 16 |
| Neuralgia | 15 |
| Pain | 11 |
| HIV Infections | 5 |
| Peripheral Nervous System Diseases | 5 |
| AIDS-Related Complex | 3 |
| Acquired Immunodeficiency Syndrome | 3 |
| Agnosia | 3 |
Trials
Showing 26 to 50 of 93. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.